Definitive Healthcare Corp (NASDAQ:DH)’s traded shares stood at 1.37 million during the last session, with the company’s beta value hitting 1.51. At the close of trading, the stock’s price was $2.79, to imply a decrease of -1.06% or -$0.03 in intraday trading. The DH share’s 52-week high remains $8.35, putting it -199.28% down since that peak but still an impressive 8.6% since price per share fell to its 52-week low of $2.55. The company has a valuation of $424.88M, with an average of 1.07 million shares in intraday trading volume over the past 10 days and average of 909.92K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Definitive Healthcare Corp (DH), translating to a mean rating of 2.71. Of 10 analyst(s) looking at the stock, 1 analyst(s) give DH a Sell rating. 0 of those analysts rate the stock as Overweight while 4 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.02.
Definitive Healthcare Corp (NASDAQ:DH) trade information
After registering a -1.06% downside in the last session, Definitive Healthcare Corp (DH) has traded red over the past five days. The 5-day price performance for the stock is 7.72%, and -46.86% over 30 days. With these gigs, the year-to-date price performance is -32.12%. Short interest in Definitive Healthcare Corp (NASDAQ:DH) saw shorts transact 2.77 million shares and set a 2.65 days time to cover.
The extremes give us $4 and $30 for target low and target high price respectively. As such, DH has been trading -975.27% off suggested target high and -43.37% from its likely low.
Definitive Healthcare Corp (DH) estimates and forecasts
The rating firms project that company’s revenue will shrink -6.83% compared to the previous financial year.
Revenue forecast for the current quarter as set by 12 analysts is 56.2M. Meanwhile, for the current quarter, a total of 12 analyst(s) estimate revenue growth to 58.29M.Earnings reports from the last fiscal year show that sales brought in 63.48M and 63.74M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -11.47% before dropping -8.55% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -70.74% for the past 5-year period. While 2025 is set for a -38.36% return in earnings, projections for the next 5 years are at -4.57% annually.
DH Dividends
Definitive Healthcare Corp has its next earnings report out on 2025-Feb-26. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Definitive Healthcare Corp (NASDAQ:DH)’s Major holders
Definitive Healthcare Corp insiders hold 7.14% of total outstanding shares, with institutional holders owning 94.68% of the shares at 101.96% float percentage. In total, 94.68% institutions holds shares in the company, led by ADVENT INTERNATIONAL CORP/MA. As of 2024-06-30, the company held over 62.49 million shares (or 53.2162% of shares), all amounting to roughly $341.22 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 4.66 million shares, or about 3.9712% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $25.46 million.
We also have MFS New Discovery Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Definitive Healthcare Corp (DH) shares. Going by data provided on Nov 30, 2024 , MFS New Discovery Fund holds roughly 3.7 shares. This is just over 3.27% of the total shares, with a market valuation of $10.31 million. Data from the same date shows that the other fund manager holds a little less at 1.47, or 1.31% of the shares, all valued at about 4.11 million.
